Feb 2021, The Netherlands started QIAsure Methylation Test implementation trial for triage of HPV positively screened women

Oct 2020 QIAsure Methylation Test validated as triage strategy for HPV positive women in a large multicenter European study

July 2020, NeuMoDx Molecular Receives CE Mark for HPV Diagnostic Test

Oct. 2019, FAM19A4/miR124-2 methylation shows higher sensitivity than cytology for detection of CIN3+ in women living with HIV

October 2019, HPV-Risk assay clinically validated on SurePath cervical screening samples

December 2018, Self-screen and Novosanis received a prestigious Eurostar grant